Ifirmacombi

Hydrochlorothiazide / Irbesartan, the active ingredient in Ifirmacombi, is a Angiotensin II receptor blocker (ARB) and thiazide diuretic combination presented as a oral tablet for oral use. It treats hypertension in adult patients.

GNH USA supplies Ifirmacombi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ifirmacombi, a combined ARB and thiazide diuretic, is used to manage hypertension.

- Hypertension: lowers systolic and diastolic blood pressure, helping to reduce the risk of cardiovascular events.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue - Increased urination - Electrolyte disturbances (e.g., low potassium) - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Hyperkalemia - Acute kidney injury - Severe allergic reactions (e.g., angioedema, rash) - Significant drop in blood pressure (hypotension) - Liver function abnormalities

Before initiating therapy, consider the following precautions: - Blood Pressure Monitoring: ensure adequate control and avoid excessive lowering. - Renal Function Assessment: check serum creatinine and eGFR, especially in patients with existing kidney disease. - Electrolyte Surveillance: monitor potassium and sodium levels regularly. - Pregnancy Considerations: avoid use unless clearly needed; discuss risks with a healthcare professional. - Concomitant Medications: review for drugs that may affect renal function or potassium balance. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Ifirmacombi may interact with several medicines. Review the following:

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - ACE inhibitors or aliskiren (in pregnancy): additive effects on renal function. - Lithium: increased lithium levels and toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce antihypertensive efficacy and impair renal function. - Antidiabetic agents: diuretic effect may affect glucose control. - Other antihypertensives: may cause additive blood pressure lowering.